Towards a single therapy against triple negative breast cancer and neuroblastoma by nucleolin-mediated multicellular targeting with a synergistic drug combination
We would like to inform you that Cookies are used on this website. To accept, click "ACCEPT" button. You can cancel your choice at any time by changing your web browser settings and deleting saved cookies.AcceptRead more